Answer
Skudexa can cause potentially fatal gastrointestinal bleeding, ulceration or perforation at any time, with or without warning symptoms or previous serious gastrointestinal events; treatment should be withdrawn if gastrointestinal bleeding or ulceration occurs.
Sources for this answer
- Skudexa 75 mg/25 mg film-coated tabletsA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.4 Special warnings and precautions for use · Version 12Document updated
Sources checked